This content is machine translated Varicella zoster virus Adjuvanted subunit vaccine offers long-lasting protection The results of ZOSTER-049 – an extension of two Phase III clinical trials – show that the adjuvanted recombinant zoster vaccine (RZV) can provide protection against shingles for a decade…
View Post 6 min This content is machine translated Varicella zoster virus Swiss vaccination recommendations for primary and secondary prophylaxis The FOPH and the Federal Commission on Vaccination recommend vaccination against herpes zoster with the adjuvanted subunit vaccine for healthy people aged 65 and over and for patients with immunodeficiency…
View Post 6 min This content is machine translated Alopecia areata: drug therapy Which method achieves the best hair growth rates? Alopecia areata (AA) manifests as acute or chronic non-scarring hair loss. Diphenylcyclopropenone and Janus kinase inhibitors have a significantly higher remission rate compared with the spontaneous course, especially in severe…
View Post 4 min This content is machine translated Shingles Herpes zoster vaccine provides long-lasting protection for adults 50 and older Interim analysis of the follow-up phase of two phase III trials show that recombinant adjuvanted zoster vaccine protects against herpes zoster for at least 10 years overall after initial vaccination.…
View Post 7 min This content is machine translated Herpes zoster in the family practice The “uninvited visitor” returns One in three people contract “shingles” once in their lifetime. The disease is very painful and can cause high suffering. The complications are also feared above all.
